China: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Key Takeaways | Leveraging China’s biotech ecosystem
A Paris roundtable examined China's transformation into a biotechnology powerhouse and the strategic opportunities this creates for European life sciences companies and investors. Industry leaders discussed how to structure cross-border partnerships that leverage Chinese innovation and development speed while navigating intellectual property protection, regulatory frameworks, and evolving geopolitical considerations.
China Healthcare
SR
McDermott Will & Schulte
Article
2026 Sees China's Biotech Scene Continuing Its Ascent – But Could US Developments Mean Clouds On The Horizon?
In recent years, China's biotech scene has risen in prominence with its innovative R&D and promising pipelines commanding big pharma's attention. In this blog, we take a look at this trend, which sees China-related deals and investment continuing to flow, as well as the recent developments in the US, with draft legislation being proposed that seeks to impose restrictions which would impact transactions between US pharma companies and Chinese biotechs. 
Worldwide Healthcare
KL
Herbert Smith Freehills Kramer LLP
See more